IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Big Growth in CRAMS Contracts for Jubilant

1:46 PM MDT | July 24, 2007 | Chemical Week Editorial Staff

Jubilant Organosys (Noida), one of India’s largest drug discovery and pharma services companies, says it has signed several custom research and manufacturing services (CRAMS) contracts worth a combined $60 million. The value of the deals represents a 50% increase over deals signed last year. Jubilant says that almost $54 million worth of contracts are with European and U.S. firms, and include deals with unspecified life science multinationals. “We will continue to focus on investments in innovation and world-class manufacturing facilities,” says...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa